FdaApplication
ANDA 214209
Identifiers
- fda_app_no: ANDA214209
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2021-02-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUMATRIPTAN | SUMATRIPTAN | 20MG/SPRAY | SPRAY;NASAL |
1 product